miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing

被引:66
|
作者
Guerau-de-Arellano, Mireia [1 ,2 ]
Alder, Hansjuerg [3 ]
Ozer, Hatice Gulcin [4 ]
Lovett-Racke, Amy [3 ]
Racke, Michael K. [1 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Neurol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
[3] Ohio State Univ, Med Ctr, Mol Virol Immunol & Med Genet Dept, Columbus, OH 43210 USA
[4] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
miRNA; Profiling; Biomarker; Multiple sclerosis; Neuroimmunology; Autoimmunity; MYELIN BASIC-PROTEIN; MICRORNA GENES; C-ELEGANS; RNA-INTERFERENCE; T-CELLS; EXPRESSION; DIFFERENTIATION; AUTOIMMUNITY; BIOGENESIS; TARGETS;
D O I
10.1016/j.jneuroim.2011.10.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. miRNAs are highly expressed in cells of the immune and nervous system, attesting to their importance in Neuroimmunology. Besides their involvement in modulation of physiological and pathological processes, miRNAs hold high promise as disease biomarkers, therapeutic agents and/or drug targets. Several studies have recently explored the involvement of miRNAs in Multiple Sclerosis (MS) using a variety of miRNA profiling techniques. In this review, we discuss basic miRNA biology and nomenclature, the techniques available for miRNA profiling research and recent miRNA profiling studies in Multiple Sclerosis. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] miRNA profiling of bilateral rat hippocampal CA3 by deep sequencing
    Shinohara, Yoshiaki
    Yahagi, Kazuko
    Kawano, Mitsuoki
    Nishiyori, Hiromi
    Kawazu, Chika
    Suzuki, Naoko
    Manabe, Ri-ichiroh
    Hirase, Hajime
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (02) : 293 - 298
  • [22] Differential miRNA expression profiling of rectal and colon cancers using deep sequencing
    Chen, Zhenbin
    Mu, Bing
    Qin, Hanjun
    Wang, Jinhui
    Wu, Xiwei
    Gao, Harry
    Li, Wenyan
    Garcia-Aguilar, Julio
    CANCER RESEARCH, 2012, 72
  • [23] Remyelination in multiple sclerosis from the miRNA perspective
    Maciak, Karina
    Dziedzic, Angela
    Saluk, Joanna
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [24] miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
    White, Nicole M. A.
    Bao, Tian Tian
    Grigull, Joerg
    Youssef, Youssef M.
    Girgis, Andrew
    Diamandis, Maria
    Fatoohi, Eman
    Metias, Maged
    Honey, R. John
    Stewart, Robert
    Pace, Kenneth T.
    Bjarnason, Georg A.
    Yousef, George M.
    JOURNAL OF UROLOGY, 2011, 186 (03): : 1077 - 1083
  • [25] Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling
    Mattoon, Down
    Michaud, Gregory
    Merkel, Janie
    Schweitzer, Barry
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (06) : 879 - 889
  • [26] Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus
    Hu, Chaojun
    Huang, Wei
    Chen, Hua
    Song, Guang
    Li, Ping
    Shan, Qiang
    Zhang, Xuan
    Zhang, Fengchun
    Zhu, Heng
    Wu, Lin
    Li, Yongzhe
    PLOS ONE, 2015, 10 (05):
  • [27] Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis
    Mycko, MP
    Papoian, R
    Boschert, U
    Raine, CS
    Selmaj, KW
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (03) : 223 - 229
  • [28] mRNA-sequencing of blood platelets as a novel biomarker in multiple sclerosis
    Leurs, C. E.
    Veld, S. G. J. G. In 't
    Sol, N.
    Strijbis, E. M. M.
    Vancura, A.
    Schweiger, M.
    Mateen, F. J.
    Tannous, B. A.
    Best, M. G.
    Teunissen, C. E.
    Killestein, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 252 - 252
  • [29] Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
    Dagley, Laura F.
    Emili, Andrew
    Purcell, Anthony W.
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (1-2) : 91 - 108
  • [30] Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis
    Huizar, Carol Chase
    Raphael, Itay
    Forsthuber, Thomas G.
    CELLULAR IMMUNOLOGY, 2020, 358